AFM13 in combination with allogeneic natural killer cells (AB-101) in relapsed or refractory Hodgkin lymphoma and CD30+ peripheral T-cell lymphoma: A phase 2 study (LuminICE) Meeting Abstract
| Authors: | Moskowitz, A.; Harstrick, A.; Emig, M.; Overesch, A.; Pinto, S.; Ravenstijn, P.; Schlüter, T.; Rubel, J.; Rebscher, H.; Graefe, T.; Lim, J.; Raymon, H.; Alexis, K. |
| Abstract Title: | AFM13 in combination with allogeneic natural killer cells (AB-101) in relapsed or refractory Hodgkin lymphoma and CD30+ peripheral T-cell lymphoma: A phase 2 study (LuminICE) |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 4855 |
| Language: | English |
| ACCESSION: | WOS:001159900800056 |
| DOI: | 10.1182/blood-2023-174250 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
